비알콜성지방간의 유병율과 병리기전에 대한 문헌적 고찰 = Overview for Prevalence and Pathology of Non-Alcoholic Fatty Liver Disease

다국어 초록 (Multilingual Abstract)

Objectives : Non-alcoholic fatty liver disease (NAFLD) is known to be increasing and becoming a health-related issue worldwide. This study aimed to analyze its prevalence and characterize NAFLD. Methods : NAFLD-related papers were surveyed via PubMed and in Korean medical journals, and then the prevalence and pathology were reviewed. Results : The prevalence of NAFLD in the general population is around 10~30% worldwide. The prevalence of NAFLD in Korea is estimated as 15~30%, which is higher than in China and Japan. The most important etiological-factors of NAFLD include central obesity resulting from excessive calorie intake and less physical activity, which lead to adiponectin hypoactivity and insulin resistance. The Oriental medicine view point of NAFLD pathology is phlegm-dampness by dysfunction of free flow in liver. Conclusions : This study provided an overview of the prevalence and pathology of NAFLD, and can support the development of a strategy for traditional Korean medicine-based prevention or treatment of NAFLD.

참고문헌 (Reference)

1 김수연, "종합검진 수진자에서 비알콜성 지방간과 대사 증후군의 연관성" 대한가정의학회 28 (28): 667-674, 2007

2 전언주, "여성 건강검진 수진자에서 비알콜성 지방간 질환과 유리T4와의 상관관계" 대한내분비학회 24 (24): 87-92, 2009

3 김홍규, "비알콜성 지방간과 대사성 질환들과의 연관성" 대한내분비학회 17 (17): 526-534, 2002

4 서상혁, "건강검진 수진자에서 비알콜성 지방간질환의 유병률 및 연관 인자들" 대한내과학회 70 (70): 26-32, 2006

5 나하영, "건강검진 수검자에서 혈중 요산 농도와 비알코올성 지방간의 관련성" 대한가정의학회 31 (31): 94-100, 2010

6 Liu Q, "role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)" 9 : 42-, 2010

7 Adams LA, "Treatment of non-alcoholic fatty liver disease" 82 (82): 315-322, 2006

8 Polyzos SA, "The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease" 12 (12): 365-383, 2010

9 Park JS, "Risk factors of nonalcoholic fatty liver in healthy medical check up" 11 (11): 379-382, 2004

10 Zelber-Sagi S, "Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures" 26 (26): 856-863, 2006

11 Williams CD, "Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study" 140 (140): 124-131, 2011

12 Williams CD, "Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study" 140 (140): 124-131, 2011

13 Amarapurkar D, "Prevalence of non- alcoholic fatty liver disease: population based study" 6 (6): 161-163, 2007

14 Zhou YJ, "Prevalence of fatty liver disease and its risk factors in the population of South China" 13 (13): 6419-6424, 2007

15 Fan JG, "Prevalence of and risk factors for fatty liver in a general population of Shanghai, China" 43 (43): 508-514, 2005

16 Chen CH, "Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults" 40 (40): 745-752, 2006

17 Park SH, "Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults" BLACKWELL PUBLISHING 21 (21): 138-143, 2006

18 Dassanayake AS, "Prevalence and risk factors for non- alcoholic fatty liver disease among adults in an urban Sri Lankan population" 24 (24): 1284-1288, 2009

19 Caballeria L, "Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain" 22 (22): 24-32, 2010

20 Abrams GA, "Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty liver disease" 40 : 475-483, 2004

21 한창우, "Palmitate로 유발된 비알코올성 지방간 모델에 대한 KH淸肝湯의 효과 연구" 대한한의학회 32 (32): 109-120, 2011

22 Das K, "Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease" 51 (51): 1593-1602, 2010

23 Clark JM, "Nonalcoholic fatty liver disease: an under-recognized cause of cryptogenic cirrhosis" 289 (289): 3000-3004, 2003

24 Perez M, "Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population" 52 (52): 174-177, 2011

25 Tsuruta G, "Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits" 45 (45): 666-672, 2010

26 Park SH, "Nonalcoholic Fatty Liver Disease and Abnormal Liver Function Test in the Health Screen Examinees: the Relationship with Insulin Resistance" 41 (41): 366-373, 2003

27 Uchil D, "Non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome" 57 : 201-204, 2009

28 Alavian SM, "Non- alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures" 29 (29): 159-163, 2009

29 Chavez-Tapia NN, "New insights into the pathophysiology of nonalcoholic fatty liver disease" 8 : 9-17, 2009

30 Neuschwander-Tetri BA, "Lifestyle modification as the primary treatment of NASH" 13 (13): 649-665, 2009

31 Lockman KA, "Interrelationships between hepatic fat and insulin resistance in non-alcoholic fatty liver disease" 6 (6): 341-347, 2010

32 Videla LA, "Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease" 12 (12): 555-558, 2006

33 Vanni E, "From the metabolic syndrome to NAFLD or vice versa" 42 (42): 320-330, 2010

34 Omagari K, "Fatty liver in non- alcoholic non-overweight Japanese adults: incidence and clinical characteristics" 17 (17): 1098-1105, 2002

35 Hong XZ, "Effects of fenofibrate and xuezhikang on high-fat diet-induced non- alcoholic fatty liver disease" 34 (34): 27-35, 2007

36 Golovanova EV, "Effectiveness of the new plant hepatoprotector--Ropren in patients with non-alcoholic steatohepatitis" (7) : 97-102, 2010

37 Yoo JY, "Effect of Saengangtanggami-bang on nonalcoholic fatty liver disease model induced by fatty liver" Spring (Spring): 143-157, 2007

38 Larter CZ, "A fresh look at NASH pathogenesis. Part 1: the metabolic movers" 25 (25): 672-690, 2010

39 Ahn JE, "A cross-sectional al study on prevalence rate and contributing factors of fatty liver diagnosed by ultrasonography" 24 (24): 195-210, 1991

40 Kim SH, "A Case of Nonalcoholic Steatohepatitis in a child patient" 31 (31): 1106-1110, 2010